Eledon Pharmaceuticals (ELDN) EBIT Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -24.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.00% |
| Sep 30, 2025 | -21.63% |
| Jun 30, 2025 | -38.63% |
| Mar 31, 2025 | -22.14% |
| Dec 31, 2024 | 24.80% |
| Sep 30, 2024 | -24.98% |
| Jun 30, 2024 | -22.08% |
| Mar 31, 2024 | -6.47% |
| Dec 31, 2023 | 48.73% |
| Sep 30, 2023 | -22.12% |
| Jun 30, 2023 | -58.69% |
| Mar 31, 2023 | -48.71% |
| Dec 31, 2022 | 67.55% |
| Sep 30, 2022 | -53.68% |
| Jun 30, 2022 | -31.43% |
| Mar 31, 2022 | -26.46% |
| Dec 31, 2021 | 84.82% |
| Sep 30, 2021 | -44.27% |
| Jun 30, 2021 | -35.71% |
| Mar 31, 2021 | -47.70% |
| Dec 31, 2020 | -44.48% |
| Sep 30, 2020 | -27.52% |
| Jun 30, 2020 | 27.02% |
| Mar 31, 2020 | -34.61% |
| Dec 31, 2019 | -3.49% |
| Sep 30, 2019 | -21.77% |
| Jun 30, 2019 | -63.71% |
| Mar 31, 2019 | 24.84% |
| Dec 31, 2018 | 25.51% |
| Sep 30, 2018 | 33.52% |
| Jun 30, 2018 | 29.19% |
| Mar 31, 2018 | 40.55% |
| Dec 31, 2017 | 30.47% |
| Sep 30, 2017 | 22.72% |
| Jun 30, 2017 | -4.24% |
| Mar 31, 2017 | 34.34% |
| Dec 31, 2016 | 12.17% |
| Sep 30, 2016 | 21.67% |